A mammoth task
Researchers have successfully extracted proteins from 600000 year old mammoth bones, using a technique that could be used to identify remains of very old extinct animals from tiny bones fragments.
Researchers have successfully extracted proteins from 600 000 year old mammoth bones, using a technique that could be used to identify remains of very old extinct animals from tiny bones fragments.
The West Runton Elephant is one of the most complete Steppe Mammoth skeletons in the world. Samples from the bones were used in a study by from the universities of York and Manchester into peptide sequencing mammoths and mastodons, published in Geochimica et Cosmochimica Acta.1
In the study, near-complete collagen sequences of mammoths, mastodons and elephants are proposed based upon available elephant genomic data and supported with LC–MALDI-MS–MS and LC–ESI-MS–MS analyses of collagen digest. Mammoth fossils were analysed to investigate the use of peptide mass spectrometry for fossil identification. Despite the age of the fossils, sufficient peptides were obtained to identify them as elephantid, and sufficient sequence variation was available to discriminate between elephantid and mammutid collagens.
Bio-archaeologist Professor Matthew Collins, from the University of York’s Department of Archaeology, said, “The time depth is absolutely remarkable. We believe protein lasts in a useful form ten times as long as DNA, which is normally only useful in discoveries of up to 100 000 years old in Northern Europe. The implications are that we can use collagen sequencing to look at very old extinct animals. It also means we can look through old sites and identify remains from tiny fragments of bone.”
1. M. Buckley, N. Larkin and M. Collins, Geochim. Cosmochim. Acta, 75(7), 2007–2016 (2011).
This story originally appeared in The Column. Click here to view that issue.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
